Skip to search formSkip to main contentSkip to account menu

diacetolol

Known as: RS-1-(4-acetamido-2-acetylphenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride, acetamide, N-(3-acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-, (+-)-, acetyl acebutolol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Circadian variations of acebutolol and its main metabolite, diacetolol pharmacokinetics were studied after a single oral… 
2001
2001
Acebutolol (ABT) is almost absorbed after oral administration, but its bioavailability is reduced because of considerable first… 
1991
1991
Thirty-two patients with hypertensive disease were treated with a cardioselective blocker of beta-adrenergic receptors acebutolol… 
1991
1991
Thirty-two patients with hypertensive disease were treated with a cardioselective blocker of beta-adrenergic receptors acebutolol… 
1985
1985
Twenty eight patients were randomly allocated into treatment or placebo groups. The treatment group received a single 400 mg oral… 
1983
1983
Pharmacokinetics of acebutolol have been studied in hypertensive aged patients (79.4 +/- 3.8 years) and in young healthy subjects… 
1982
1982
The beta-blocking action of diacetolol was studied in six healthy subjects after oral administration of placebo, 200, 400, and… 
1982
1982
The pharmacokinetics of acebutolol and its major N-acetyl metabolite diacetolol were determined following acute intravenous and… 
1981
1981
Acebutolol is a cardioselective /8-adrenoceptor blocking drug and has a major metabolite, diacetolol (Meffin, Harapat & Harrison…